Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Fsd Pharma Inc Cl B (HUGE)

Fsd Pharma Inc Cl B (HUGE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 36,382
  • Shares Outstanding, K 40,424
  • Annual Sales, $ 0 K
  • Annual Income, $ -35,290 K
  • 60-Month Beta 0.52
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.80
Trade HUGE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.64
  • Most Recent Earnings -0.14 on 05/13/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 82.00% ( -51.96%)
  • Historical Volatility 67.05%
  • IV Percentile 2%
  • IV Rank 6.35%
  • IV High 335.33% on 03/16/22
  • IV Low 64.83% on 11/02/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 33
  • Volume Avg (30-Day) 42
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 4,270
  • Open Int (30-Day) 4,659

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8107 +7.96%
on 05/12/22
1.0400 -15.85%
on 05/02/22
-0.1348 (-13.35%)
since 04/22/22
3-Month
0.8000 +9.40%
on 03/17/22
1.1100 -21.15%
on 04/21/22
-0.0347 (-3.81%)
since 02/23/22
52-Week
0.8000 +9.40%
on 03/17/22
2.2500 -61.10%
on 06/03/21
-0.8248 (-48.52%)
since 05/21/21

Most Recent Stories

More News
InvestmentPitch Media Video Discusses FSD Pharma, a Life Sciences Holding Company, and the Closing of its Sale of Non-Core Assets for $16.4 million

VANCOUVER, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a life sciences holding company...

HUGE : 0.8752 (-2.76%)
HUGE.CN : 1.170 (-3.31%)
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is...

HUGE : 0.8752 (-2.76%)
HUGE.CN : 1.170 (-3.31%)
FSD Pharma Announces Dismissal of Derivative Complaint

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced...

HUGE : 0.8752 (-2.76%)
HUGE.CN : 1.170 (-3.31%)
FSD Pharma Announces Engagement with Tekkfund Capital and Share Issuance to Crystal Research Associates

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced...

HUGE : 0.8752 (-2.76%)
HUGE.CN : 1.170 (-3.31%)
FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Board

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced...

HUGE : 0.8752 (-2.76%)
HUGE.CN : 1.170 (-3.31%)
GILD : 63.66 (-0.28%)
BMY : 76.70 (+0.67%)
PFE : 52.88 (+0.78%)
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced...

HUGE : 0.8752 (-2.76%)
HUGE.CN : 1.170 (-3.31%)
FSD Pharma Issues Corporate Updates

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced...

HUGE : 0.8752 (-2.76%)
HUGE.CN : 1.170 (-3.31%)
FSD Pharma Announces Filing of Year-End 2021 Results

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced...

HUGE : 0.8752 (-2.76%)
HUGE.CN : 1.170 (-3.31%)
FSD Pharma Announces Executive Informational Overview Report Produced by Crystal Research Associates LLC

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced...

HUGE : 0.8752 (-2.76%)
HUGE.CN : 1.170 (-3.31%)
InvestmentPitch Media Video Discusses FSD Pharma’s, a Life Sciences Holding Company, Agreement to Sell Former Cannabis Processing Facility in Cobourg, Ontario for $16,500,000 – Video Available on Investmentpitch.com

VANCOUVER, British Columbia, Feb. 28, 2022 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9), a life sciences holding company...

HUGE : 0.8752 (-2.76%)
HUGE.CN : 1.170 (-3.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

FSD Pharma Inc. produces medical cannabis primarily in Canada. The company focuses on the development of indoor pharmaceutical grade cannabis; research and development of cannabinoid-based treatments for central nervous system disorders. FSD Pharma Inc. is based in Seattle, Washington.

See More

Key Turning Points

3rd Resistance Point 1.0268
2nd Resistance Point 0.9784
1st Resistance Point 0.9268
Last Price 0.8752
1st Support Level 0.8268
2nd Support Level 0.7784
3rd Support Level 0.7268

See More

52-Week High 2.2500
Fibonacci 61.8% 1.6961
Fibonacci 50% 1.5250
Fibonacci 38.2% 1.3539
Last Price 0.8752
52-Week Low 0.8000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar